BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 10891528)

  • 1. Experimental animal models of pancreatic cancer (review).
    Shi Q; Xie K
    Int J Oncol; 2000 Aug; 17(2):217-25. PubMed ID: 10891528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mouse Models of Metastatic Pancreatic Adenocarcinoma.
    Xie K; Wang B; Shi Q; Abbruzzese J; Xiong Q; Le X
    Int J Gastrointest Cancer; 2001; 29(1):25-36. PubMed ID: 12754402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mouse models of metastatic pancreatic adenocarcinoma.
    Xie K; Wang B; Shi Q; Abbruzzese JL; Xiong Q; Le X
    Int J Pancreatol; 2001; 29(1):25-35. PubMed ID: 11558630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental animal models of pancreatic carcinogenesis and metastasis.
    Wei D; Xiong HQ; Abbruzzese JL; Xie K
    Int J Gastrointest Cancer; 2003; 33(1):43-60. PubMed ID: 12909737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of metastatic behavior of parental and metastatic pancreatic cancer cell lines in Syrian golden hamsters.
    Morioka CY; Saito S; Machado MC; Ohzawa K; Yamago GI; Bacchella T; Watanabe A
    In Vivo; 2004; 18(1):63-6. PubMed ID: 15011753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pigment epithelium-derived factor gene therapy inhibits human pancreatic cancer in mice.
    Hase R; Miyamoto M; Uehara H; Kadoya M; Ebihara Y; Murakami Y; Takahashi R; Mega S; Li L; Shichinohe T; Kawarada Y; Kondo S
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8737-44. PubMed ID: 16361561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subcutaneously inoculated cells and implanted pancreatic cancer tissue show different patterns of metastases in Syrian golden hamsters.
    Morioka CY; Saito S; Ohzawa K; Asano S; Hibino Y; Nakada Y; Kita KI; Watanabe A
    JOP; 2000 Nov; 1(4):183-90. PubMed ID: 11856860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-time optical imaging of primary tumor growth and multiple metastatic events in a pancreatic cancer orthotopic model.
    Bouvet M; Wang J; Nardin SR; Nassirpour R; Yang M; Baranov E; Jiang P; Moossa AR; Hoffman RM
    Cancer Res; 2002 Mar; 62(5):1534-40. PubMed ID: 11888932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the development of models in mice of advanced visceral metastatic disease for anti-cancer drug testing.
    Man S; Munoz R; Kerbel RS
    Cancer Metastasis Rev; 2007 Dec; 26(3-4):737-47. PubMed ID: 17846863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific peptide ligand for Grb7 signal transduction protein and pancreatic cancer metastasis.
    Tanaka S; Pero SC; Taguchi K; Shimada M; Mori M; Krag DN; Arii S
    J Natl Cancer Inst; 2006 Apr; 98(7):491-8. PubMed ID: 16595785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VEGF antisense therapy inhibits tumor growth and improves survival in experimental pancreatic cancer.
    Hotz HG; Hines OJ; Masood R; Hotz B; Foitzik T; Buhr HJ; Gill PS; Reber HA
    Surgery; 2005 Feb; 137(2):192-9. PubMed ID: 15674201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The genetics of pancreatic adenocarcinoma: a roadmap for a mouse model.
    Bardeesy N; Sharpless NE; DePinho RA; Merlino G
    Semin Cancer Biol; 2001 Jun; 11(3):201-18. PubMed ID: 11407945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of molecular biology studies to gene therapy treatment strategies.
    Gustin A; Pederson L; Miller R; Chan C; Vickers SM
    World J Surg; 2002 Jul; 26(7):854-60. PubMed ID: 11960211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Models of pancreatic cancer.
    Hall PA; Lemoine NR
    Cancer Surv; 1993; 16():135-55. PubMed ID: 8348533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of oncolytic reovirus against liver metastasis from pancreatic cancer in immunocompetent models.
    Himeno Y; Etoh T; Matsumoto T; Ohta M; Nishizono A; Kitano S
    Int J Oncol; 2005 Oct; 27(4):901-6. PubMed ID: 16142304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term survival in metastatic pancreatic cancer. A case report and review of the literature.
    Spinelli GP; Zullo A; Romiti A; Di Seri M; Tomao F; Miele E; Spalletta B; Eramo A; Hassan C; Tomao S
    JOP; 2006 Sep; 7(5):486-91. PubMed ID: 16998247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limitations in improving detection of pancreatic adenocarcinoma.
    Mendieta Zerón H; García Flores JR; Romero Prieto ML
    Future Oncol; 2009 Jun; 5(5):657-68. PubMed ID: 19519205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenocarcinoma of the pancreas--past, present and future.
    Lygidakis NJ; Jain S; Sacchi M; Vrachnos P
    Hepatogastroenterology; 2005; 52(64):1281-92. PubMed ID: 16001679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The molecular genetics of pancreatic ductal carcinoma.
    Sohn TA
    Minerva Chir; 2002 Oct; 57(5):561-74. PubMed ID: 12370658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant radiation is associated with improved survival in patients with resectable pancreatic cancer: an analysis of data from the surveillance, epidemiology, and end results (SEER) registry.
    Stessin AM; Meyer JE; Sherr DL
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1128-33. PubMed ID: 18538501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.